Bio-Nanomedicine for Cancer Therapy

05.02.2021

Englisch

9783030581732

Springer International Publishing

Advances in Experimental Medicine and Biology

Nein

360

1st edition 2021

Gebundene Ausgabe

Hélder A. Santos is a Full Professor in Pharmaceutical Nanotechnology, Principal Investigator/Group Leader, Director of the Doctoral Program in Drug Research, and Head of the Nanomedicines and Biomedical Engineering Group at the Faculty of Pharmacy, University of Helsinki (Finland). He is also the Director of the FinPharmNet and Chair of Controlled Release Society Focus Group in Nanomedicine and Nanoscale Delivery. Prof. Santos’ research is focused on nanobiomaterials, nanovaccines, inorganic and and polymeric-based nanomedicines for controlled drug delivery, diagnostics and therapy. The research interests include the development of nanomedicines for biomedical and healthcare applications. His current work makes the bridge between engineering, pharmaceutical and medical research. His main research focus is in the use of biodegradable and biocompatible nanomaterials for simultaneous controlled drug delivery, diagnostic and treatment of cancer, diabetes, and cardiovascular diseases, and^ 8800 citations, h-index = 56), and more than 260 conference proceedings/abstracts.

Biohybrid, Nanotechnology, Cancer nanotechnology, Vaccines nantechnology, Drug delivery systems nanotechnology

TCB - Biotechnologie MJCL - Onkologie TJF - Elektronik MQW - Biomedizinische Technik

279 mm

21 cm